- Recommendation ID
- NG198/1
- Question
What is the efficacy of reduced dose oral isotretinoin in the management of acne vulgaris?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made the recommendation for research, see the rationale section on oral isotretinoin treatment .
Full details of the evidence and the committee's discussion are in evidence review F1: management options for moderate to severe acne – network meta-analyses.
Source guidance details
- Comes from guidance
- Acne vulgaris: management
- Number
- NG198
- Date issued
- June 2021
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 01/01/2024 |